Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response
Open Access
- 24 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 13 (4), R82
- https://doi.org/10.1186/bcr2934
Abstract
Hypoxia in solid tumors is associated with treatment resistance, resulting in poor prognosis. Tribbles homolog 3 (TRIB3) is induced during hypoxia and is involved in multiple cellular pathways involved in cell survival. Here, we investigated the role of TRIB3 in breast cancer. TRIB3 mRNA expression was measured in breast tumor tissue from 247 patients and correlated with clinicopathological parameters and clinical outcome. Furthermore, we studied TRIB3 expression regulation in cell lines, xenografts tissues and human breast cancer material using Reverse transcriptase, quantitative polymerase chain reaction (RT-qPCR) and immunohistochemical staining. Finally, the effect of small interfering RNA (siRNA) mediated TRIB3 knockdown on hypoxia tolerance was assessed. Breast cancer patients with low, intermediate or high TRIB3 expression exhibited a mean disease free survival (DFS) of 80 (95% confidence interval [CI] = 74 to 86), 74 (CI = 67 to 81), and 63 (CI = 55 to 71) months respectively (P = .002, Mantel-Cox log-rank). The prognostic value of TRIB3 was limited to those patients that had received radiotherapy as part of their primary treatment (n = 179, P = .005) and remained statistically significant after correction for other clinicopathological parameters (DFS, Hazard Ratio = 1.90, CI = 1.17 to 3.08, P = .009). In breast cell lines TRIB3 expression was induced by hypoxia, nutrient starvation, and endoplasmic reticulum stress in an hypoxia inducible factor 1 (HIF-1) independent manner. TRIB3 induction after hypoxia did not increase with decreasing oxygen levels. In breast tumor xenografts and human breast cancer tissues TRIB3 co-localized with the hypoxic cell marker pimonidazole. The induction of TRIB3 by hypoxia was shown to be regulated via the PERK/ATF4/CHOP pathway of the unfolded protein response and knockdown of TRIB3 resulted in a dose-dependent increase in hypoxia sensitivity. TRIB3 is independently associated with poor prognosis of breast cancer patients, possibly through its association with tumor cell hypoxia.Keywords
This publication has 50 references indexed in Scilit:
- The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5JCI Insight, 2009
- Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosisBritish Journal of Cancer, 2009
- Targeting tumour hypoxia in breast cancerEuropean Journal of Cancer, 2008
- The impact of O2 availability on human cancerNature Reviews Cancer, 2008
- Phosphorylation of eIF2α is required for mRNA translation inhibition and survival during moderate hypoxiaRadiotherapy and Oncology, 2007
- Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human CancersPLoS Medicine, 2006
- ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growthThe EMBO Journal, 2005
- PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3Nature Medicine, 2004
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970